Goldman Sachs Bonus Zert CEC 26.0.../ DE000GQ6DVF9 /
6/10/2024 11:36:22 AM | Chg.- | Bid9:00:18 AM | Ask9:00:18 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.18EUR | - | 2.17 Bid Size: 10,000 |
- Ask Size: - |
CECONOMY AG INH O.N... | - EUR | 6/26/2024 | Call |
GlobeNewswire
9:05 AM
LIFT intersects 25 m at 1.21% Li2O at its Shorty pegmatite, Yellowknife Lithium Project, NWT
GlobeNewswire
9:00 AM
Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service p...
GlobeNewswire
8:20 AM
Himax to Make Strategic Investment in FOCI Private Placement Financing; Companies to Unite FOCI’s Wo...
GlobeNewswire
8:15 AM
ROHM’s New TRCDRIVE pack™ with 2-in-1 SiC Molded Module: Significantly Reduces the Size of Electric ...
GlobeNewswire
8:00 AM
FTI Consulting Appoints Senior Forensic Expert Dr. Stefan Heissner to the Forensic and Litigation Co...
GlobeNewswire
8:00 AM
Bedford Metals Engages CanExplor Management for Satellite Survey of Ubiquity Lake Uranium Project
GlobeNewswire
8:00 AM
Viridien Joins Forces with Ranch Computing to Supercharge the Digital Media Landscape
GlobeNewswire
7:45 AM
GRITSTONE BIO, INC. (NASDAQ: GRTS) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securitie...
GlobeNewswire
7:00 AM
Nykode Therapeutics Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy
GlobeNewswire
7:00 AM
Feutune Light Acquisition Corporation Announces that It Will Adjourn the Special Meeting of Stockhol...
GlobeNewswire
7:00 AM
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPi...
GlobeNewswire
7:00 AM
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients